(NASDAQ: MDWD) Mediwound's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 15.2%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 34.27%.
Mediwound's earnings in 2026 is -$23,879,000.On average, 8 Wall Street analysts forecast MDWD's earnings for 2026 to be -$36,024,410, with the lowest MDWD earnings forecast at -$41,634,653, and the highest MDWD earnings forecast at -$28,436,270. On average, 8 Wall Street analysts forecast MDWD's earnings for 2027 to be -$26,729,196, with the lowest MDWD earnings forecast at -$32,955,526, and the highest MDWD earnings forecast at -$18,867,668.
In 2028, MDWD is forecast to generate -$16,277,535 in earnings, with the lowest earnings forecast at -$18,993,452 and the highest earnings forecast at -$9,703,372.